Immunotherapy employing dendritic cell vaccination for patients with advanced or relapsed esophageal cancer
Author:
Affiliation:
1. Department of Internal Medicine Sapporo Hokuyu Hospital Sapporo Japan
2. Institute for Artificial Organ, Transplantation and Cell Therapy Sapporo Hokuyu Hospital Sapporo Japan
3. Cell Processing Center Sapporo Hokuyu Hospital Sapporo Japan
Publisher
Wiley
Subject
Nephrology,Hematology
Link
https://onlinelibrary.wiley.com/doi/pdf/10.1111/1744-9987.13542
Reference21 articles.
1. The Global Burden of Cancer 2013
2. Nivolumab versus chemotherapy in patients with advanced oesophageal squamous cell carcinoma refractory or intolerant to previous chemotherapy (ATTRACTION-3): a multicentre, randomised, open-label, phase 3 trial
3. Safety and Antitumor Activity of the Anti–Programmed Death-1 Antibody Pembrolizumab in Patients With Advanced Esophageal Carcinoma
4. Multicenter, phase II clinical trial of cancer vaccination for advanced esophageal cancer with three peptides derived from novel cancer-testis antigens
5. Clinical Trial of the Intratumoral Administration of Labeled DC Combined With Systemic Chemotherapy for Esophageal Cancer
Cited by 9 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Wilms’ tumor 1 -targeting cancer vaccine: Recent advancements and future perspectives;Human Vaccines & Immunotherapeutics;2023-12-26
2. Prognostic model construction and immune microenvironment analysis of esophageal cancer based on gene expression data and microRNA target genes;Translational Cancer Research;2023-05
3. Natural peptides for immunological regulation in cancer therapy: Mechanism, facts and perspectives;Biomedicine & Pharmacotherapy;2023-03
4. Immune-based combination therapy for esophageal cancer;Frontiers in Immunology;2022-12-15
5. Wilms' tumor 1 peptide‐loaded dendritic cell vaccination in patients with relapsed or refractory acute leukemia;Therapeutic Apheresis and Dialysis;2022-03-10
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3